Cabot earnings were $190.0M for the trailing 12 months ending Jun 30, 2026, with -53.8% growth year over year. The latest CBT earnings report on Jun 30, 2026 announced Q2 2026 earnings of $6.0M, down 91.2% from last quarter. For the last reported fiscal year 2025 ending Sep 30, 2025, CBT reported annual earnings of $331.0M, with -12.9% growth.
CBT past earnings growth
How has CBT's earnings growth performed historically?
On CBT's earnings call on Aug 3, 2026, Cabot (NYSE: CBT) reported Q2 2026 earnings per share (EPS) of $0.12, up 93.58% year over year. Total CBT earnings for the quarter were $6.00 million. In the same quarter last year, Cabot's earnings per share (EPS) was $1.87.
As of the last Cabot earnings report, Cabot is currently profitable. Cabot's net profit (also called net income) for the twelve months ending Jun 30, 2026 was $190.00 million, a 55.29% decrease year over year.
What was CBT's earnings growth in the past year?
As of Cabot's earnings date in Aug 3, 2026, Cabot's earnings has grown -53.76% year over year. This is 61.27 percentage points lower than the US Specialty Chemicals industry earnings growth rate of 7.52%. CBT earnings in the past year totalled $190.00 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.